Fundraising Fox
Spot Biosystems
5 known investors
Find your way into Spot Biosystems
Sign up to see every warm intro you have to Spot Biosystems
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spot Biosystems team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Spot Biosystems is a clinical-stage biopharmaceutical company developing non-viral gene therapies using extracellular vesicles as a delivery method. The company targets genetic diseases including muscular dystrophy and cardiac conditions.
Investors · 5
Saltagen Ventureslisted by Saltagen VenturesHong Kong
How we know: Saltagen Ventures's portfolio page · funding news · Not right? Tell us
StartXlisted by StartXStanford · $10K – $1M
How we know: StartX's portfolio page · Not right? Tell us
Advantech CapitalreportedCamana Bay
How we know: funding news · Not right? Tell us
IDG CapitalreportedHong Kong · $1M – $100M
How we know: funding news · Not right? Tell us
LDV PartnersreportedPalo Alto
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Spot Biosystems do?
- Spot Biosystems is a clinical-stage biopharmaceutical company developing non-viral gene therapies using extracellular vesicles as a delivery method. The company targets genetic diseases including muscular dystrophy and cardiac conditions.
- Who are Spot Biosystems's investors?
- Spot Biosystems's investors include Saltagen Ventures, StartX, Advantech Capital, IDG Capital, LDV Partners.